Parsons Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-81,825
| Closed | -$56K | – | 417 |
|
2020
Q4 | $56K | Sell |
81,825
-88,092
| -52% | -$60.3K | ﹤0.01% | 373 |
|
2020
Q3 | $382K | Sell |
169,917
-4,420
| -3% | -$9.94K | 0.04% | 269 |
|
2020
Q2 | $624K | Buy |
174,337
+26,735
| +18% | +$95.7K | 0.07% | 210 |
|
2020
Q1 | $561K | Buy |
147,602
+39,767
| +37% | +$151K | 0.07% | 207 |
|
2019
Q4 | $325K | Buy |
+107,835
| New | +$325K | 0.03% | 291 |
|